Rx only · Injection, Solution · Subcutaneous

Mirikizumab-Mrkz

Brands: Omvoh · Mirikizumab

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US4 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCL04AC24

RxCUI (US)2668384

US makers1 labelers

Packages6

DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

146

Rx · 2026 Q1

312

Units dispensed

+30%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Eli Lilly and Company	unknown	6	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Dec 22, 2025
RESOLVEDShortage resolved: Mirikizumab-mrkz Injection (Eli Lilly and Co.)
Mirikizumab-mrkz Injection — reported in shortage by Eli Lilly and Co.. Therapeutic category: Gastroenterology, Other.
Dec 22, 2025
SHORTAGEDrug shortage: Mirikizumab-mrkz Injection (Eli Lilly and Co.)
Mirikizumab-mrkz Injection — reported in shortage by Eli Lilly and Co.. Therapeutic category: Gastroenterology, Other.